Cover Image
市場調查報告書

深層腦部刺激器的全球市場:2016∼2020年

Global Deep Brain Stimulation Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 356751
出版日期 內容資訊 英文 61 Pages
訂單完成後即時交付
價格
Back to Top
深層腦部刺激器的全球市場:2016∼2020年 Global Deep Brain Stimulation Market 2016-2020
出版日期: 2016年04月15日 內容資訊: 英文 61 Pages
簡介

腦深部刺激(DBS)系統是腦刺激之一,把電擊刺激送到腦的目標領域,調整病變部位的腦細胞和神經原做出的電訊號。全球腦深部刺激市場,預計2016∼2020年,以年複合成長率10.59%擴大。

本報告提供全球深層腦部刺激器市場現狀與至2020年的成長預測,市場趨勢與課題,各地區趨勢,主要供應商簡介等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 腦深部刺激的潛在應用

第6章 腦深部刺激系統的結構零件和植入成本

第7章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第8章 用途市場區隔

  • 帕金森氏症
  • 肌張力不全症
  • 威脅性障礙
  • 癲癇

第9章 各地區市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第10章 推動市場的要素

第11章 促進要素的影響

第12章 市場課題

第13章 促進要素與課題的影響

第14章 市場趨勢

第15章 供應商環境

  • 競爭模式
  • 市場佔有率分析

第16章 主要供應商分析

  • Boston Scientific
  • Medtronic
  • St. Jude Medical
  • 其他值得注意的供應商

第17章 附錄

第18章 關於Technavio

圖表

目錄
Product Code: IRTNTR8784

About Deep Brain Stimulation

A neurostimulation system, also known as a neurostimulator, provides therapeutic activation or modulation in the nervous system at targeted anatomical sites. Deep brain stimulation (DBS) system, a type of neurostimulator, generates electrical stimulation to the targeted areas of the brain and regulates the electrical signals that are generated by the diseased brain cells and neurons.

Technavio's analysts forecast the global DBS market to grow at a CAGR of 10.59% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global DBS market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of various types of DBS systems.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Deep Brain Stimulation Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Boston Scientific Corp.
  • Medtronic plc
  • St. Jude Medical Inc.

Other Prominent Vendors

  • Adaptive Neuromodulation
  • Aleva Neurotherapeutics
  • Beijing Pins Medical
  • NeuroPace
  • NeuroSigma

Market driver

  • Increased number of market approvals
  • For a full, detailed list, view our report

Market challenge

  • High cost of DBS therapy
  • For a full, detailed list, view our report

Market trend

  • Hybrid neuroprosthetic devices
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights
  • Approved indications for DBS therapy
  • History of DBS

PART 05: Potential applications of DBS

PART 06: Cost of DBS system components and implantation

PART 07: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 08: Market segmentation by application

  • PD
  • Dystonia
  • OCD
  • Epilepsy

PART 09: Geographical segmentation

  • DBS market in Americas
  • DBS market in EMEA
  • DBS market in APAC

PART 10: Market drivers

  • Increase in prevalence of neurological disorders
  • Availability of funds and grants for R&D
  • Increased number of market approvals

PART 11: Impact of drivers

PART 12: Market challenges

  • High cost of DBS therapy
  • Complications related to DBS
  • High maintenance and low battery lifetime

PART 13: Impact of drivers and challenges

PART 14: Market trends

  • Hybrid neuroprosthetic devices
  • Next-generation therapies for nervous system disorders
  • Emergence of clinician programmer

PART 15: Vendor landscape

  • Competitive scenario
  • Market share analysis

PART 16: Key vendor analysis

  • Boston Scientific
  • Medtronic
  • St. Jude Medical
  • Other prominent vendors

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Neurological conditions and their symptoms treated by DBS therapy
  • Exhibit 03: History of DBS
  • Exhibit 04: Conditions under investigation for DBS therapy
  • Exhibit 05: Cost of DBS implantation and treatment
  • Exhibit 06: Cost difference between DBS and pharmacological and follow-up cost 2015
  • Exhibit 07: Cost breakdown of DBS components 2015
  • Exhibit 08: Cost breakdown of pharmacological and follow-up cost in DBS 2015
  • Exhibit 09: Adverse event cost (due to surgical error) of DBS implantation 2015
  • Exhibit 10: Global DBS market by revenue 2015-2020 ($ millions)
  • Exhibit 11: Five forces analysis
  • Exhibit 12: Global DBS market segmentation by application 2015
  • Exhibit 13: Global DBS market by application 2015
  • Exhibit 14: Global DBS market by geography 2015
  • Exhibit 15: Global DBS market by geography 2020
  • Exhibit 16: Conditions treated by DBS in the US
  • Exhibit 17: Economic burden of diseases in the US
  • Exhibit 18: DBS market in Americas 2015-2020 ($ millions)
  • Exhibit 19: Prevalence and financial burden of neurodegenerative diseases in Europe 2010
  • Exhibit 20: DBS market in EMEA 2015-2020 ($ millions)
  • Exhibit 21: DBS market in APAC 2015-2020 ($ millions)
  • Exhibit 22: Global DBS market by geography 2015-2020
  • Exhibit 23: Global DBS market by geography 2015-2020 ($ millions)
  • Exhibit 24: Research funding for DBS
  • Exhibit 25: Regulatory approvals for DBS System
  • Exhibit 26: Impact of drivers
  • Exhibit 27: Impact of drivers and challenges
  • Exhibit 28: Boston Scientific: Product portfolio
  • Exhibit 29: Boston Scientific: Neuromodulation segment by revenue 2012-2014 ($ millions)
  • Exhibit 30: Boston Scientific: Key takeaways
  • Exhibit 31: Medtronic: Product portfolio
  • Exhibit 32: Medtronic: Neuromodulation segment by revenue 2013-2015 ($ billions)
  • Exhibit 33: Medtronic: Key takeaways
  • Exhibit 34: St. Jude Medical: Product portfolio
  • Exhibit 35: St. Jude Medical: Neuromodulation segment by revenue 2012-2014 ($ millions)
  • Exhibit 36: St. Jude Medical: Key takeaways
Back to Top